Searchable abstracts of presentations at key conferences in endocrinology

ea0063p656 | Interdisciplinary Endocrinology 1 | ECE2019

Epidemiological characteristics of transsexual people referred to a single-center during its first fifteen years in Catania (Italy)

Vetri Mario , Cataldi Alessia , Naselli Adriano

Gender Dysphoria (GD) is defined as incongruence between gender identity and physical phenotype. This condition exists in different psychological typologies: male-to-female (MtF) and female-to-male (FtM) transsexualism. In most cases the first manifestations can occur even during childhood. The transition project is a long and difficult path that involves a multidisciplinary team including endocrinologists, psychologist and plastic surgeons. Our study aims to describe socio-de...

ea0063p657 | Interdisciplinary Endocrinology 1 | ECE2019

Endocrinological management of male-to-female (MtF) transgender persons: a single center experience during the last decade

Vetri Mario , Naselli Adriano , Cataldi Alessia

In MtFs therapy with oestrogens and antiandrogens, actually considered the best strategy, requires a careful baseline and follow-up hormonal evaluation. We conducted a retrospective analysis to define the most frequent hormonal treatment prescribed and the relationship between the dosage and patientsÂ’ hormonal changes. Among 85 pts referring to us between March 2003 and June 2018 with a mean age of 28.4 years we have selected 42 treated with Oestradiol Valerate (OV) and C...

ea0063p658 | Interdisciplinary Endocrinology 1 | ECE2019

Endocrinological management of female-to-male (FtM) transgender persons: a single center experience during the last decade

Vetri Mario , Naselli Adriano , Cataldi Alessia

In FtMs testosterone (TE) therapy is used to pursue the dual objective of suppressing female secondary sex characteristics and inducing a male phenotype to the patient. Between October 2001 and December 2018, an heterogeneous group of 32 patients (Pts) with a mean age of 27.7 years presented to our Center for FtM Gender Dysphoria. We analyzed Body Mass Index (BMI), haemochrome and hormonal (LH, FSH, Prolactin) measurements comparing baseline levels to post-therapy. A total of ...